Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders
Main Authors: | A. Bayas, A. Berthele, B. Hemmer, C. Warnke, B. Wildemann |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Neurological Research and Practice |
Online Access: | https://doi.org/10.1186/s42466-021-00139-8 |
Similar Items
-
MOG-IgG associated optic neuritis is not multiple sclerosis
by: Bruna Klein da Costa, et al. -
Association of smoking with risk of multiple sclerosis and neuromyelitis optica spectrum disorders
by: Ting-ting YANG, et al.
Published: (2016-09-01) -
Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
by: Hai Chen, et al.
Published: (2016-01-01) -
Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
by: Burak Arslan, et al.
Published: (2021-08-01) -
Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes
by: Marco A. Lana-Peixoto, et al.
Published: (2019-06-01)